Literature DB >> 15365749

Correlation of endorectal coil magnetic resonance imaging of the prostate with pathologic stage.

Stephen A Brassell1, William R Krueger, Jong-Ho Choi, John A Taylor.   

Abstract

The aim was to evaluate the pretreatment efficacy of endorectal coil (ERC) MRI in accurately predicting extracapsular extension in a group of intermediate risk patients. A total of 40 intermediate risk patients were identified who underwent pretreatment ERC MRI and subsequent radical prostatectomy (RP). Imaging studies and pathologic analysis were compared with respect to presence of extracapsular extension (ECE), involvement of seminal vesicles, and appearance of regional nodes. Mean age was 62 years, PSA 14.8, and most common stage was cT2a/pT2c and Gleason 6. ERC MRI has a positive predictive value of 81%, specificity 89%, and odds ratio 6.47 in determining extracapsular extension. Conversely, its sensitivity is only 43%, with a negative predictive value of 59%. ERC MRI may be useful as an adjunctive study for intermediate risk patients due to its high specificity and positive predictive value, thereby adding information to the clinical decision-making process.

Entities:  

Mesh:

Year:  2004        PMID: 15365749     DOI: 10.1007/s00345-004-0440-x

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  12 in total

1.  Three-dimensional computer-simulated prostate models: lateral prostate biopsies increase the detection rate of prostate cancer.

Authors:  J J Bauer; J Zeng; J Weir; W Zhang; I A Sesterhenn; R R Connelly; S K Mun; J W Moul
Journal:  Urology       Date:  1999-05       Impact factor: 2.649

2.  Re: The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.

Authors:  M Roach
Journal:  J Urol       Date:  1993-12       Impact factor: 7.450

3.  Cancer control with radical prostatectomy alone in 1,000 consecutive patients.

Authors:  Gerald W Hull; Farhang Rabbani; Farhat Abbas; Thomas M Wheeler; Michael W Kattan; Peter T Scardino
Journal:  J Urol       Date:  2002-02       Impact factor: 7.450

4.  Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer.

Authors:  A V D'Amico; R Whittington; B Malkowicz; M Schnall; D Schultz; K Cote; J E Tomaszewski; A Wein
Journal:  J Urol       Date:  2000-09       Impact factor: 7.450

5.  Extent of extracapsular extension in localized prostate cancer.

Authors:  C Sohayda; P A Kupelian; H S Levin; E A Klein
Journal:  Urology       Date:  2000-03       Impact factor: 2.649

6.  The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer.

Authors:  A W Partin; J Yoo; H B Carter; J D Pearson; D W Chan; J I Epstein; P C Walsh
Journal:  J Urol       Date:  1993-07       Impact factor: 7.450

7.  A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancer.

Authors:  Lars Holmberg; Anna Bill-Axelson; Fred Helgesen; Jaakko O Salo; Per Folmerz; Michael Häggman; Swen-Olof Andersson; Anders Spångberg; Christer Busch; Steg Nordling; Juni Palmgren; Hans-Olov Adami; Jan-Erik Johansson; Bo Johan Norlén
Journal:  N Engl J Med       Date:  2002-09-12       Impact factor: 91.245

8.  Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques.

Authors:  C M Tempany; X Zhou; E A Zerhouni; M D Rifkin; L E Quint; C W Piccoli; J H Ellis; B J McNeil
Journal:  Radiology       Date:  1994-07       Impact factor: 11.105

9.  Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results.

Authors:  W J Catalona; D S Smith
Journal:  J Urol       Date:  1998-12       Impact factor: 7.450

10.  The impact of the inclusion of endorectal coil magnetic resonance imaging in a multivariate analysis to predict clinically unsuspected extraprostatic cancer.

Authors:  A V D'Amico; R Whittington; M Schnall; S B Malkowicz; J E Tomaszewski; D Schultz; A Wein
Journal:  Cancer       Date:  1995-05-01       Impact factor: 6.860

View more
  5 in total

1.  Accuracy of preoperative endo-rectal coil magnetic resonance imaging in detecting clinical under-staging of localized prostate cancer.

Authors:  Antonio B Porcaro; Alessandro Borsato; Mario Romano; Teodoro Sava; Claudio Ghimenton; Filippo Migliorini; Carmelo Monaco; Emanuele Rubilotta; Stefano Zecchini Antoniolli; Vincenzo Lacola; Stefania Montemezzi
Journal:  World J Urol       Date:  2012-07-07       Impact factor: 4.226

Review 2.  Role of magnetic resonance imaging and magnetic resonance spectroscopic imaging before and after radiotherapy for prostate cancer.

Authors:  Antonio C Westphalen; David A McKenna; John Kurhanewicz; Fergus V Coakley
Journal:  J Endourol       Date:  2008-04       Impact factor: 2.942

3.  Incremental value of high b value diffusion-weighted magnetic resonance imaging at 3-T for prediction of extracapsular extension in patients with prostate cancer: preliminary experience.

Authors:  Ayumu Kido; Tsutomu Tamada; Teruki Sone; Naoki Kanomata; Yoshiyuki Miyaji; Akira Yamamoto; Katsuyoshi Ito
Journal:  Radiol Med       Date:  2016-12-09       Impact factor: 3.469

Review 4.  Value of magnetic resonance imaging in prostate cancer diagnosis.

Authors:  Friedrich Aigner; Leo Pallwein; Alexandre Pelzer; Georg Schaefer; Georg Bartsch; Dieter zur Nedden; Ferdinand Frauscher
Journal:  World J Urol       Date:  2007-06-14       Impact factor: 4.226

5.  High spectral and spatial resolution MRI of age-related changes in murine prostate.

Authors:  Sean Foxley; Xiaobing Fan; Sanaz A Jansen; Marta Zamora; Erica Markiewicz; Hikmat Al-Ahmadie; Gregory S Karczmar
Journal:  Magn Reson Med       Date:  2008-09       Impact factor: 4.668

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.